Copyright Reports & Markets. All rights reserved.

Global Chronic Idiopathic Constipation (CIC) Drugs Market Data Survey Report 2013-2025

Buy now

Table of Contents

    1 Global Market Overview

    • 1.1 Scope of Statistics
      • 1.1.1 Scope of Products
      • 1.1.2 Scope of Manufacturers
      • 1.1.3 Scope of Application
      • 1.1.4 Scope of Type
      • 1.1.5 Scope of Regions/Countries
    • 1.2 Global Market Size

    2 Regional Market

    • 2.1 Regional Production
    • 2.2 Regional Demand
    • 2.3 Regional Trade

    3 Key Manufacturers

    • 3.1 Actavis
      • 3.1.1 Company Information
      • 3.1.2 Product & Services
      • 3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.1.4 Recent Development
    • 3.2 Chugai Pharmaceutical
      • 3.2.1 Company Information
      • 3.2.2 Product & Services
      • 3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.2.4 Recent Development
    • 3.3 Ferring International Center
      • 3.3.1 Company Information
      • 3.3.2 Product & Services
      • 3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.3.4 Recent Development
    • 3.4 Synergy Pharmaceuticals
      • 3.4.1 Company Information
      • 3.4.2 Product & Services
      • 3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.4.4 Recent Development
    • 3.5 Pfizer
      • 3.5.1 Company Information
      • 3.5.2 Product & Services
      • 3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.5.4 Recent Development
    • 3.6 GlaxoSmithKline
      • 3.6.1 Company Information
      • 3.6.2 Product & Services
      • 3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.6.4 Recent Development
    • 3.7 Roche Holding
      • 3.7.1 Company Information
      • 3.7.2 Product & Services
      • 3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.7.4 Recent Development
    • 3.8 Sanofi
      • 3.8.1 Company Information
      • 3.8.2 Product & Services
      • 3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.8.4 Recent Development
    • 3.9 Bayer
      • 3.9.1 Company Information
      • 3.9.2 Product & Services
      • 3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.9.4 Recent Development
    • 3.10 Salix Pharmaceuticals
      • 3.10.1 Company Information
      • 3.10.2 Product & Services
      • 3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.10.4 Recent Development
    • 3.11 Sucampo Pharmaceuticals
      • 3.11.1 Company Information
      • 3.11.2 Product & Services
      • 3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.11.4 Recent Development
    • 3.12 Ironwood Pharmaceuticals
      • 3.12.1 Company Information
      • 3.12.2 Product & Services
      • 3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 3.13 Progenics Pharmaceuticals
      • 3.13.1 Company Information
      • 3.13.2 Product & Services
      • 3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

    4 Major Application

    • 4.1 Hospitals & Clinics
      • 4.1.1 Overview
      • 4.1.2 Hospitals & Clinics Market Size and Forecast
    • 4.2 Ambulatory Surgical Centres
      • 4.2.1 Overview
      • 4.2.2 Ambulatory Surgical Centres Market Size and Forecast
    • 4.3 Long Term Care Centres
      • 4.3.1 Overview
      • 4.3.2 Long Term Care Centres Market Size and Forecast
    • 4.4 Others
      • 4.4.1 Overview
      • 4.4.2 Others Market Size and Forecast

    5 Market by Type

      5.By Lubiprostone

      • 5.1 Lubiprostone
        • 5.1.1 Overview
        • 5.1.2 Lubiprostone Market Size and Forecast
      • 5.2 Linaclotide
        • 5.2.1 Overview
        • 5.2.2 Linaclotide Market Size and Forecast
      • 5.3 Others
        • 5.3.1 Overview
        • 5.3.2 Others Market Size and Forecast

      6 Price Overview

      • 6.1 Price by Manufacturers
      • 6.2 Price by Application
      • 6.3 Price by Type

      7 Conclusion

      Summary
      The global Chronic Idiopathic Constipation (CIC) Drugs market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
      Global market size and forecast
      Regional market size, production data and export & import
      Key manufacturers profile, products & services, sales data of business
      Global market size by Major Application
      Global market size by Major Type
      Key manufacturers are included based on company profile, sales data and product specifications etc.:
      Actavis
      Chugai Pharmaceutical
      Ferring International Center
      Synergy Pharmaceuticals
      Pfizer
      GlaxoSmithKline
      Roche Holding
      Sanofi
      Bayer
      Salix Pharmaceuticals
      Sucampo Pharmaceuticals
      Ironwood Pharmaceuticals
      Progenics Pharmaceuticals
      Major applications as follows:
      Hospitals & Clinics
      Ambulatory Surgical Centres
      Long Term Care Centres
      Others
      Major Type as follows:
      Lubiprostone
      Linaclotide
      Others
      Regional market size, production data and export & import:
      Asia-Pacific
      North America
      Europe
      South America
      Middle East & Africa

      Buy now